Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Effectiveness of Covishield vaccine in preventing Covid-19 – A test-negative case-control study

Stuti Pramod, Dhanajayan Govindan, Premkumar Ramasubramani, View ORCID ProfileSitanshu Sekhar Kar, Rakesh Aggarwal, JIPMER vaccine effectiveness study group, Nandhini Manoharan, Palanivel Chinnakali, Mahalakshmy Thulasingam, Sonali Sarkar, Molly Mary Thabah
doi: https://doi.org/10.1101/2021.07.19.21260693
Stuti Pramod
Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dhanajayan Govindan
Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Premkumar Ramasubramani
Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sitanshu Sekhar Kar
Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sitanshu Sekhar Kar
  • For correspondence: drsitanshukar@gmail.com
Rakesh Aggarwal
Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
Nandhini Manoharan
Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Palanivel Chinnakali
Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahalakshmy Thulasingam
Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonali Sarkar
Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Molly Mary Thabah
Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction This study was aimed at assessing the vaccine effectiveness (VE) of Covishield, which is identical to the AstraZeneca vaccine, in preventing laboratory-confirmed Covid-19.

Methods Using a test-negative case-control design, information on vaccination status of cases with Covid-19 among healthcare workers in our institution in Puducherry, India, and an equal number of matched controls, i.e., positive and negative for SARS-CoV-2 by RT-PCR, was obtained. The cases and controls were matched for age (±3 years) and date of testing (±3 days). The groups were compared using multivariable conditional logistic regression to calculate odds ratios (OR), with adjustment for gender, occupational role, presence of symptoms and presence of a comorbidity condition. Per cent vaccine effectiveness (VE) was calculated as 100 x (1-adjusted odds ratio).

Results Using data from 360 case-control pairs, VE of one dose and of two doses, in providing protection against Covid-19 was 49% (95% CI: 17%-68%) and 54% (27%-71%), respectively. In view of a difference in the proportion of cases and controls who had symptoms, a separate analysis of data from 203 pairs where both the case and the control had symptoms was done, which showed VE of 58% (28%-75%) and 64% (38%-78%) after one dose and two doses, respectively. Among cases with moderately severe disease that required oxygen therapy, VE following any number of vaccine doses was 95% (44%-100%).

Conclusion Covishield vaccine protected significantly against Covid-19, with the protection after two doses being slightly higher than after one dose, and a particularly high protection rate against severe forms of disease.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors received no specific funding for this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was permitted by the Institute’s (Jawaharlal Institute of Postgraduate Medical Education and Research) Ethics Committee (Project No. JIP/IEC/2021/233).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

As per the institute’s ethics guidelines, the ethics committee reserves the rights on the datasets which protects the privacy of research data for up to three years after completion of the studies. Therefore, the dataset cannot be shared at this point in time. In case of any further queries or clarifications regarding the institute’s ethics guidelines on sharing of research data, the committee may be contacted through their official email: iechumanstudiesjipmer{at}gmail.com The data may be accessed from the JIPMER Ethics Committee (contact: iechumanstudiesjipmer{at}gmail.com) after three years of completion of the project, for those who meet institute’s criteria for access to confidential data.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted July 22, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Effectiveness of Covishield vaccine in preventing Covid-19 – A test-negative case-control study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effectiveness of Covishield vaccine in preventing Covid-19 – A test-negative case-control study
Stuti Pramod, Dhanajayan Govindan, Premkumar Ramasubramani, Sitanshu Sekhar Kar, Rakesh Aggarwal, JIPMER vaccine effectiveness study group, Nandhini Manoharan, Palanivel Chinnakali, Mahalakshmy Thulasingam, Sonali Sarkar, Molly Mary Thabah
medRxiv 2021.07.19.21260693; doi: https://doi.org/10.1101/2021.07.19.21260693
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Effectiveness of Covishield vaccine in preventing Covid-19 – A test-negative case-control study
Stuti Pramod, Dhanajayan Govindan, Premkumar Ramasubramani, Sitanshu Sekhar Kar, Rakesh Aggarwal, JIPMER vaccine effectiveness study group, Nandhini Manoharan, Palanivel Chinnakali, Mahalakshmy Thulasingam, Sonali Sarkar, Molly Mary Thabah
medRxiv 2021.07.19.21260693; doi: https://doi.org/10.1101/2021.07.19.21260693

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (238)
  • Allergy and Immunology (520)
  • Anesthesia (124)
  • Cardiovascular Medicine (1414)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (582)
  • Epidemiology (10273)
  • Forensic Medicine (6)
  • Gastroenterology (526)
  • Genetic and Genomic Medicine (2618)
  • Geriatric Medicine (254)
  • Health Economics (496)
  • Health Informatics (1728)
  • Health Policy (788)
  • Health Systems and Quality Improvement (671)
  • Hematology (266)
  • HIV/AIDS (564)
  • Infectious Diseases (except HIV/AIDS) (12074)
  • Intensive Care and Critical Care Medicine (647)
  • Medical Education (272)
  • Medical Ethics (83)
  • Nephrology (287)
  • Neurology (2450)
  • Nursing (144)
  • Nutrition (376)
  • Obstetrics and Gynecology (487)
  • Occupational and Environmental Health (566)
  • Oncology (1317)
  • Ophthalmology (398)
  • Orthopedics (145)
  • Otolaryngology (235)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (342)
  • Pediatrics (776)
  • Pharmacology and Therapeutics (328)
  • Primary Care Research (295)
  • Psychiatry and Clinical Psychology (2392)
  • Public and Global Health (4991)
  • Radiology and Imaging (892)
  • Rehabilitation Medicine and Physical Therapy (522)
  • Respiratory Medicine (681)
  • Rheumatology (309)
  • Sexual and Reproductive Health (254)
  • Sports Medicine (244)
  • Surgery (296)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)